Efficacy and tolerability of the Subcutaneous Semaglutide for type 2 Diabetes patients: an updated systematic review and meta-analysis.
Journal Information
Full Title: Diabetol Metab Syndr
Abbreviation: Diabetol Metab Syndr
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Endocrinology & Metabolism
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Competing interestsThe authors declare no competing interests. Ethics approval and consent to participateThis article does not contain any studies with human participants or animals performed by any of the authors. Consent for publicationNot applicable. Competing interests The authors declare no competing interests."
"Funding This work was supported by the Research Fund for Clinical Pharmacy of China International Medical Foundation (Z-2021-46-2101 Hu); National Natural Science Foundation of China (81973289 Fan)."
"This research was operated according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [, ], which protocol was registered in PROSPERO (CRD42021264640)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025